Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CLDI

Calidi Biotherapeutics Inc

Jun 08 • 03:45PM ET

0.1728

+0.0038 2.25 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.18	Insider Own	10.11%	Shs Outstand	19.31M	Perf Week	-5.83%
Market Cap	3.33M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.04%	Shs Float	17.36M	Perf Month	-20.18%
Enterprise Value	-1.14M	PEG	-	EPS next Q	-	Inst Own	10.39%	Short Float	3.86%	Perf Quarter	-52.72%
Income	-25.01M	P/S	-	EPS this Y	-	Inst Trans	4.58%	Short Ratio	0.15	Perf Half Y	-88.78%
Sales	0.00M	P/B	0.41	EPS next Y	-	ROA	-202.88%	Short Interest	0.67M	Perf YTD	-85.23%
Book/sh	0.42	P/C	0.50	EPS next 5Y	-	ROE	-421.19%	52W High	19.20 -99.10%	Perf Year	-95.96%
Cash/sh	0.35	P/FCF	-	EPS past 3/5Y	74.50% -	ROIC	-439.70%	52W Low	0.16 9.58%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.96% 9.09%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	76.55%	Oper. Margin	-	ATR (14)	0.02	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.96	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.92	EPS Q/Q	80.60%	SMA20	-5.35%	Beta	1.30	Target Price	120.00
Payout	-	Debt/Eq	0.46	Sales Q/Q	-	SMA50	-20.33%	Rel Volume	0.48	Prev Close	0.17
Employees	29	LT Debt/Eq	0.15	Earnings	May 14 AMC	SMA200	-82.29%	Avg Volume	4.51M	Price	0.17
IPO	Nov 01, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	2,090,435	Change	2.25%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)